|
HY-100233-1mL
|
MedChemexpress LLC
|
IQ-1S (free acid) [CAS 23146-22-7] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-132269-10mg
|
MedChemexpress LLC
|
Isoflupredone [CAS 338-95-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-132269-25mg
|
MedChemexpress LLC
|
Isoflupredone [CAS 338-95-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-132269-5mg
|
MedChemexpress LLC
|
Isoflupredone [CAS 338-95-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-132269-50mg
|
MedChemexpress LLC
|
Isoflupredone [CAS 338-95-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-132269-1mL
|
MedChemexpress LLC
|
Isoflupredone [CAS 338-95-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-103583-1mg
|
MedChemexpress LLC
|
KDU731 [CAS 1610610-48-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103583-10mg
|
MedChemexpress LLC
|
KDU731 [CAS 1610610-48-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103583-5mg
|
MedChemexpress LLC
|
KDU731 [CAS 1610610-48-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1791B-10mg
|
MedChemexpress LLC
|
Lactoferrin (17-41) (acetate) [CAS 2828433-30-1]
|
|
Cancer-programmed cell death
|
|
|
HY-P1791B-5mg
|
MedChemexpress LLC
|
Lactoferrin (17-41) (acetate) [CAS 2828433-30-1]
|
|
Cancer-programmed cell death
|
|
|
HY-P78900-10ug
|
MedChemexpress LLC
|
LILRB1/CD85j/ILT2, Human (Biotinylated, HEK293, Fc-Avi)
|
|
|
|
|
HY-P78900-5ug
|
MedChemexpress LLC
|
LILRB1/CD85j/ILT2, Human (Biotinylated, HEK293, Fc-Avi)
|
|
|
|
|
HY-P78900-50ug
|
MedChemexpress LLC
|
LILRB1/CD85j/ILT2, Human (Biotinylated, HEK293, Fc-Avi)
|
|
|
|
|
HY-129960-100mg
|
MedChemexpress LLC
|
L-Selenocystine [CAS 29621-88-3]
|
|
|
|
|
HY-129960-250mg
|
MedChemexpress LLC
|
L-Selenocystine [CAS 29621-88-3]
|
|
|
|
|
HY-Y0293-100mg
|
MedChemexpress LLC
|
L-Tartaric acid [CAS 87-69-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-Y0293-500mg
|
MedChemexpress LLC
|
L-Tartaric acid [CAS 87-69-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-Y0293-1mL
|
MedChemexpress LLC
|
L-Tartaric acid [CAS 87-69-4] (10mM in DMSO)
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-137296-100mg
|
MedChemexpress LLC
|
Lumogallion [CAS 4386-25-8]
|
|
|
|
|
HY-137296-50mg
|
MedChemexpress LLC
|
Lumogallion [CAS 4386-25-8]
|
|
|
|
|
HY-18614-10mg
|
MedChemexpress LLC
|
LY900009 [CAS 209984-68-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-18614-25mg
|
MedChemexpress LLC
|
LY900009 [CAS 209984-68-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-18614-5mg
|
MedChemexpress LLC
|
LY900009 [CAS 209984-68-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-18614-50mg
|
MedChemexpress LLC
|
LY900009 [CAS 209984-68-9]
|
|
Neuroscience-Neurodegeneration
|
|
